The association of Type 1 (insulin dependent) diabetes with certain DR antigens indicates that a major part of its genetic susceptibility is located close to, or within, the HLA-D (class II HLA) region. Recent studies have pointed to the DQ subregion as a potential determinant of disease predisposition [1] [2] [3] [4] [5] [6] [7] [8] [9] . Identification of the primary susceptibility locus (or loci) is complicated, however, by linkage disequilibrium. This refers to the strong tendency of HLA alleles to co-associate non-randomly to form specific haplotype combinations. HLA linkage relationships vary in different races, and, thus, comparison of HLA-disease associations in distinct ethnic populations may define the primary site of genetic predisposition [10] .
The relative risk for Type 1 diabetes conferred by certain DR antigens shows racial variation. DRw9, for example, is increased in frequency in diabetic patients of Japanese origin [11] , but the relative risk for this antigen in Caucasoid subjects is close to one [12] . This variation suggests that the serologically-defined DR antigens do not correspond directly to disease susceptibility alleles, but it may help to identify these factors. If an antigen shows a race-specific association with Type 1 diabetes, the question arises "what allele is found on haplotypes bearing this antigen in the race(s) in which it is diabetes-associated, which is absent from haplotypes bearing the same antigen in other populations?". The genetic locus encoding this allele will be a candidate for a primary determinant of genetic susceptibility to Type 1 diabetes.
In an attempt to define race-specific disease associations, we have serologically DR-typed Negroid patients with Type 1 diabetes and racially-matched control subjects. Associations thus defined were further investigated by restriction fragment length polymorphism (RFLP) analysis using DNA probes corresponding to the DQcx, DQ[~ and DR[~ chain genes.
Subjects and methods

Subjects
Type 1 diabetic patients and control subjects were UK residents of Afro-Caribbean (predominantly Jamaican) Negroid racial origin, with no known Caucasoid ancestry. Control subjects were healthy un- 
Results
related individuals with no personal or family history of diabetes. All patients fulfilled the classic clinical criteria for insulin-dependence (see Table 1 ).
Memo&
Patients and control subjects were studied by: (1) serological HLA-DR-typing (39 patients and 80 control subjects). (2) DQc~, DQ[} and DR[3 RFLP analysis (39 patients and 77 control subjects). DR-typing was by a standard microlymphocytotoxicity method using commercially prepared typing trays (Biotest, Birmingham, UK). These trays are in routine clinical use in the United Kingdom for tissue typing prior to bone marrow transplantation. DR1-5 & 7 were determined in all subjects. DRw6, w8, w9 and wl0 were defined in all 39 patients and in 64 control subjects. The typing trays included the following numbers of specific antisera: DR1 -four; DR2 -five; DR3 -five; DR4 -five; DR5 -five; DR7 -five; DRw8 -two; DRwl0 -two. For DRw6, five antisera were included, two of which were crossreactive with DR3, and three of which cross-reacted with the other DQwl-related antigens DR1, 2 and wl0. For DRw9, three antisera were employed, two of which cross-reacted with DR4 and one of which cross-reacted with DR1 and wl0. DR antigen assignments were confirmed by DPq3 probing (see below "Restriction fragment length polymorphism analysis").
For the RFLP studies, DNA was isolated from peripheral blood. Ten ug DNA were digested with restriction enzymes BamHI, Eco RI or TaqI under conditions recommended by the manufacturer (BRL, Glasgow, UK). Digested DNA was separated by eleetrophoresis in 0.7% agarose at 50 V, 25 mA for 18 h (TaqI and BamHI digests) or 22 h (EcoRI digests) and Southern blotted onto nylon filters (Hybond-N, Amersham Int., Amersham, UK) [13] . Three cDNA probes were used: (1) 
HLA-DR serological analysis
The DR antigen frequencies in Negroid diabetic patients and control subjects are shown in Table 2 . DR4 was markedly increased in frequency in the patients, but was rare in the control population (38.5% vs 2.5%; RR--20 (5.4-74); Pc < 10-4). DR3 was non-significantly increased in frequency in patients compared with control subjects (38.5% vs 26.3%; RR=I.8 (0.81-4.0)), as were DR7 (28.2% vs 11.3%; RR=3.0 (1.2-7.7)) and DRw9 (23.1% vs 4.7%; RR= 5.5 (1.6-19)). DR3/4 heterozygosity was non-significantly increased in frequency in patients compared with control subjects (10.3% vs 0%). DR3, DR4, or both antigens, were found in 66.7% patients and 28.8% control subjects (RR= 4.8 (2.2-11); pc < 0.001). DR3, DR4, DR7 or DRw9 (or any two of these antigens) were found in 36/39 (92.3%) patients and 28/64 (43.8%) control subjects (RR= 13 (4.3-42); p~< 10-5).
DR2 was reduced in frequency in patients vs control subjects (5.1% vs 30.0%; RR=0.15 (0.04-0.55); pc<0.025), as was DR5 (7.7% vs 42.5%; RR=0.13 (0.04-0.40); pc < 0.002).
Combined analys&
In view of the increased frequency (non-significant) of DR3, DR7 and DRw9 in this study, combined analysis of these data with those of all previously published studies of DR antigens in Negroid subjects with Type 1 diabetes [17] [18] [19] [20] [21] [22] [23] was performed, to determine whether there were significant associations with these markers (only four published studies tested for DRw9 [20] [21] [22] [23] ).
The combined RR estimate for DR3 was 1.94 (1.48-2.53); this was significantly different from one (X 2 (1 df) = 23.5; Pc < 0.001). Further analysis indicated significant variation (heterogeneity) among RR estimates for DR3 (X 2 (7 dr) = 18.8; p < 0.01). Removal of a data set derived from a study in American Negroid patients [17] (which gave a relatively high RR estimate for DR3 (5.9)) from the analysis gave non-significant heterogeneity (p> 0.05), and a combined RR value for DR3 of 1.71 (1.29-2.27). This was significantly different from one (Pc< 0.002).
The combined RR estimate for DR7 was 1.71 (1.25-2.35). This was significantly different from one (X 2 (1 df) = 11.1 ; Pc < 0.01). The RR estimates showed significant variation (X 2 (7 df)=17.3; p<0.025). Removal of a data set derived from a study of Ethiopian Negroid subjects [23] (in which DR7 was reduced in diabetic patients) from the analysis gave non-significant heterogeneity (p> 0.2), and a combined RR value for DR7 of 1.95 (1.41-2.70). This was significantly different from one (Pc < 0.001).
The combined RR estimate for DRw9 was 4.53 (2.23-9.19) (X 2 (1 df) = 17.5; Pc < 0.001). The RR estimates were not significantly heterogeneous (X 2 (4 df) = 2.2; p > 0.5).
J. Fletcher et al.: Racial studies implicate HLA-DQ in Type 1 (insulin-dependent) diabetes Restriction fragment length polymorphism analysis DQ[~ RFLPs were the same as those previously described in Caucasoid subjects [10, 24, 25] , apart from a novel pattern, found only in Negroid subjects, designated DQ[~VIIc. Table 3 shows the restriction fragments for each DQ[~ RFLP. Correlations between the DQ[~ DNA fragment patterns obtained with the three restriction enzymes (BamHI, TaqI and EcoRI) were based on (1) published studies which analysed DQ[5 polymorphism with these three restriction enzymes in homozygous typing cells [25] and in pedigrees [3] , and (2) the empirical observation that the correlations defined in these studies were also seen in Afro-Caribbean patients and control subjects. DQ[3VIIc has not been previously recognised, but the other RFLPs listed in Table 3 are known to be DQ[~-specific [3] . BamHI fragments were the same for DQ[3VIIb and DQ[~VIIc. The distinction was made by a TaqI 4 kb fragment in DQ[~VIIc, instead of the 8 kb fragment characteristic of DQ[~VIIb (see Fig. 1 ). The DQ-specificity of DQ[~VIIc was supported by the observation that the 4 kb fragment gave a strong hybridisation signal, and that it was not visible on filters rehybridised with DR[~ probe. EcoRI fragments also varied, with an 18 kb fragment in DQ[~VIIb and a 13kb fragment in DQ[SVIIc. The frequencies of the DQ[~ RFLPs are shown in Table 4 . DQ[~VIIc was markedly increased in frequency in patients compared with control subjects (48.7% vs 10.4%; R R = 7.8 (3.1-20); Pc < 10-4). DQ[3VIIb showed no association. DQ[~III was also increased in patients vs control subjects (35.9% vs 13.0%; RR=3.7 (1.5-9.1); pc< 0.04). DQ[~IV was non-significantly increased in RFLPs defined with DR[3 and DQc~ probes were the same as those seen in Caucasoid subjects [10, 24, 25] . DR[3 RFLPs defined with TaqI were classified into seven patterns which are listed in Table 5 . These patterns correlate closely with serologically-defined DRtypes [10, 24, 25] . DQa probing with TaqI defined fragments of size 2.6, 4.6, 5.5, 6.2 and 6.8 kb which are known to represent alleles of the DQa gene [26] .
Relationships between DR antigens and DQ and DR RFLPs
There were close associations (due to linkage disequilibrium) between DR antigens and DQoc and DQ[3 RFLPs. Table 6 shows the DR antigen-DQ[3 RFLP relationships (defined in control subjects), and Table 7 shows, for selected DR antigens, the most commonly associated DR[3/DQ[3/DQa RFLP combinations. Many of the associations were similar to those previously found in Caucasoid subjects [10, 24, 25] , but the following differences were seen in Negroid subjects: (1) the novel RFLP, DQ[3VIIc, was found in association with DRw9 and a subset of DR7. (2) DR3 was in linkage disequilibrium with DQ[3III (as in Caucasoid subjects), but also showed an association with DQ[3IV not seen in Caucasoid subjects. (3) DQ[3VIa was strongly associated with DR2 (as in white Caucasoid subjects), but there was also a weaker (non-significant) association with DR5.
Of eight DR7-positive control subjects tested, six had DQ[3VIIb, one had DQ[3VIIc and one had DQ[3IV. Among eleven DR7-positive diabetic patients, seven had DQ[3VIIc and five had DQ[3VIIb (one patient was heterozygous for the two RFLPs). DR7 was thus increased in frequency in patients only in combination with DQ[3VIIc (RR=9.8 (2.0-49); p<0.01). DR7 in combination with DQ[3VIIb was neutral (RR=I.4 (0.44-4.5); p= NS). DR7-DQ[3IV was not seen in any patient. DRw9 was closely associated with DQ[3VIIc, in both patients and control subjects (RR for DRw9-DQ[3VIIc=5.5 (1.6-19); p<0.01). DR7-associated DQot and DR[3 RFLPs were as described for DR7 haplotypes in Caucasoid subjects [10, 24, 25] (see Table 7 ).
In control subjects, DR3 was associated with either DQ[3III or DQ[3IV. DR[~ and DQc~ RFLPs also differed between these two subsets of DR3 (see Table 7 DQ[3VIa was significantly associated with DR2, but was also found in 12/22 DR5-positive control subjects. In six of these subjects, the presence of DQ[~VIa could be accounted for by the second DR antigen (DR2 or DRw6), but in the remaining six subjects, this was not the case. DQ[3VIa was absent from the three DR5-positive patients.
Discussion
The Afro-Caribbean population of the United Kingdom is of recent origin, being principally derived from a wave of migration which occurred during the 1950s and 1960s. Our selection criteria excluded patients and control individuals with post-migration Caucasoid ancestry and our subjects are, therefore, genetically representative of the indigenous Negroid population of the Caribbean region. Current knowledge of HLA associations with Type 1 diabetes in Negroid subjects has relied heavily on studies from the United States, but the American Negroid population has a substantial proportion (approximately 20%) of Caucasoid genetic admixture [27] . In the Negroid population of Jamaica, Caucasoid admixture has been estimated at 10% [27] , and thus, the subjects of the present study are genetically closer to the West African Negroid peoples from whom both American and Caribbean Negroid subjects are descended.
Our analysis indicated that four DR antigens are increased in frequency in Negroid patients with Type 1 diabetes -DR3, 4, 7 and w9. In all other races studied, DR7 is reduced in frequency in patients [28] , and, thus, this antigen is a race-specific marker. Ethiopian Negroid patients do not appear to show this association [23] , possibly due to their distinct Negroid-Caucasoid ancestry. DRw9 shows only a weak predisposing effect in Caucasoid patients [12] , but is increased in Japanese diabetic patients [11] . The DR4 association has been noted in previous studies of Negroid subjects [17] [18] [19] [20] 23] . In Caucasoid subjects, the relative risk for DR3 is three to four [29] , but our analysis indicated a value of approximately two for Negroid subjects. There was significant variation in relative risk estimates for DR3 in Negroid subjects, which may be due to Caucasoid genetic admixture in some of the populations studied. Both DR2 and DR5 were significantly reduced in frequency in Negroid patients with Type 1 diabetes. In Caucasoid subjects, the negative association of DR2 is well-recognised, but DR5 does not consistently confer a marked protective effect.
To investigate further these racial differences in DR antigen associations, we studied class II HLA RFLPs with DNA probes corresponding to the DQ~, DQ[3 and DR[3 chain genes.
DRw9, and a subset of DR7, were associated with a DQ[3 pattern (DQ[3VIIc) which has not been previously identified in other races [10, 24, 25] . This pattern was associated with DQ~ and DR~ RFLPs which are also characteristic of Caucasoid DR7 and DRw9 haplotypes [10, 24, 25] . The frequency of DQ~VIIc was markedly increased among Negroid diabetic patients compared with control subjects. As in Caucasoid subjects [10] , DR7-DQ[~VIIb was not increased in Type 1 diabetes. These results suggest that the positive associations of DR7 and DRw9 with Type 1 diabetes in Negroid subjects correlate with variation in the DQ subregion on DR7 and DRw9 haplotypes in this race. DNA sequencing of the class II genes on the diabetes-associated DR7 haplotype is now required to confirm the results of RFLP analysis.
The other DQ[~ patterns seen in Negroid subjects are also found in Caucasoid subjects [10, 24, 25] . Their linkage disequilibrium relationships with DR antigens were also similar to those seen in the latter groups, with certain important exceptions. In Caucasoids, one DQ RFLP pattern, DQ[3III-DQ~4.6 kb, is found in the great majority of DR3-positive subjects (patients and controls). This pattern corresponds to the DR3-DQw2 haplotype. In Negroids, DR3 in control subjects was associated with two patterns -DQ~III-DQoc4.6 kb, and DQ[~IV-DQ~6.2 kb. This split has recently been recognised by others [30] . The latter pattern corresponds to the DR3-DQ"blank" haplotype, present in approximately 50% of DR3-positive American Negroid subjects [30] . DNA sequence analysis has shown that the DR3-DQ"blank" and DR3-DQw2 DQ0c chains are very similar, but the DR3-DQ"blank" DQ[3 chain is similar to that previously described for a DR4-DQ"blank" haplotype [30] .
In the present study, only the DR3-DQw2 pattern was increased in frequency in Negroid patients, whereas the DR3-DQ"blank" pattern was absent from this group. The negative association of DR3-DQ"blank" with Type 1 diabetes explains the lower relative risk for DR3 in Negroid subjects compared with Caucasoid subjects, and is consistent with the view that the DR3-related component of genetic susceptibility to Type 1 diabetes is DQ-related. No firm conclusion can be reached regarding the relative roles of DR and DQ in DR3-related susceptibility, however, because DR3-DQw2 and DR3-DQ"blank" have distinct DR[3 RFLPs, implying that their DR~ chains are also different.
DQ[~VIa is associated with DR2 in Caucasoid subjects and with DRw6 in North Indian subjects but has a protective effect against Type 1 diabetes in both groups [10] . In Negroid subjects, DQ[3VIa was strongly associated with DR2, but there was also evidence for an association with DR5. Although the latter association was not statistically significant, it is known that DR5 haplotypes frequently carry DQwl (of which DQ[~VIa is a subset) in Negroid subjects [31] . As in white Caucasoid and North Indian subjects, DQ[3VIa in Negroid subjects was markedly reduced in frequency in patients with Type 1 diabetes. Thus, a single DQ[3 pattern with varying DR antigen associations in different races confers a consistent protective effect against Type 1 diabetes, supporting the view that a component of susceptibility to the condition is DQ-encoded.
Two DQ-defined subsets of DR4 -DQw3.1 and DQw3.2 -have been described using serology and RFLP analysis; DQw3.1 correlates with a positive reaction with TA10 antisera, whereas DQw3.2 is TA10-negative [32] . In our terminology, DQ[3IV is characteristic of DQw3.2, and DQ[~V corresponds to DQw3A. Current evidence indicates that DQw3.2 is present in approximately 90% of DR4-positive Caucasoid diabetic patients, whereas DQw3.1 is reduced in frequency in patients [9] . This has been interpreted as evidence that DR4 susceptibility is DQ-encoded. If, however, the negative association of DR4-DQw3A with Type i diabetes is a general phenomenon, then the low frequency of DR4 in the Afro-Caribbean Negroid control population should lead to a very low frequency of DR4-DQ[~V in patients of this race. In the present study, however, four of fifteen DR4-positive patients had DQ[~V rather than DQ[3IV. DQ may not, therefore, be the only locus influencing susceptibility to Type 1 diabetes on DR4 haplotypes. This view is supported by a recent study of DR4-DQw3 subtypes (defined by TA10 serology) in Caucasoid patients, which found that the specific positive association of DR4-DQw3.2 with Type 1 diabetes may only apply to DR3/4 heterozygous subjects; among DR4-positive, DR3-negative patients the frequencies of DQw3.1 and 3.2 were similar to those found in DR4-positive control subjects [33] .
In conclusion, trans-racial genetic analysis indicates that the DQ region has a primary role in determining predisposition to Type 1 diabetes. This is supported by two lines of evidence from this study. First, the increased frequencies of DR7 and DRw9 in Type 1 diabetes in Negroid subjects correlated with the association of these antigens with a novel DQ[~ RFLP which was markedly increased in frequency among patients. Second, a DQ[~ RFLP in linkage disequilibrium with different DR antigens in three races, confers a consistent protective effect against Type 1 diabetes. Furthermore, our results are compatible with a model in which the DR3 association is mediated by HLA-DQ. Studies in Caucasoid subjects support a role for DQ in DR4-related susceptibility also, but the possibility of an additional non-DQ component of DR4 predisposition cannot be excluded.
